William Blair maintains Outperform rated on Cabaletta Bio Inc. (CABA) amid trial progress
William Blair analyst Sami Corwin reiterated an Outperform rating on Cabaletta Bio Inc. (NASDAQ: CABA)The analyst commented, "In our view ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
